Galactose-alpha-1,3-galactose syndrome: an Italian survey
D. Villalta1 danilo.villalta@aas5.sanita.fvg.it, L. Cecchi2, A. Farsi2, F. Chiarini2, P. Minale3 et al.Show more: Authors information and Publication historyFull list of Authors: D. Villalta
1, L. Cecchi
2, A. Farsi
2, F. Chiarini
2, P. Minale
3, S. Voltolini
3, E. Scala
4, O. Quercia
5, L. Muratore
6, V. Pravettoni
7, A.M. Calamari
8, G. Cortellini
9, R. Asero
10
1 Immunologia e Allergologia, Ospedale "S. Maria degli Angeli", Pordenone, Italy
2 SOS Allergologia e Immunologia Clinica, USL Toscana Centro, Prato, Italy
3 SOC di Allergologia, IRCCS S. Martino - IST, Genova, Italy
4 Istituto Dermopatico dell'Immacolata - IRCCS, Roma, Italy
5 Unità ad Alta Specializzazione di Allergologia, Ospedale di Faenza, Faenza, Italy
6 Allergy and Clinical Immunology Service, Vito Fazio Hospital, Lecce, Italy
7 UOC Clinical Allergy and Immunology, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
8 Ospedale Castelli, Pallanza, Italy
9 UO di Medicina Interna e Reumatologia, Azienda Sanitaria della Romagna, Rimini, Italy
10 Ambulatorio di Allergologia, Clinica S. Carlo, Paderno Dugnano, Milan, Italy
Publication History:
Published online: 2 November 2017
Accepted: 8 September 2017
Received: 26 January 2017
Doi
https://doi.org/10.23822/EurAnnACI.1764-1489.35 SummaryBackground. The term of á-Gal syndrome, which includes the delayed allergy to red meat and the allergic reactions following the administration of cetuximab, is associated to the presence of specific IgE to á-Gal. In Italy, only anecdotal cases were reported so far. The Association of Italian Allergists (AAITO) carried out a survey with the aim of evaluating presence, characteristics, clinical features, and distribution of the syndrome in Italy.
Methods. A web structured questionnaire was made available on the website of AAIITO from July 2016 to January 2017. It included 31 multiple-choice questions concerning different items, including the site of physicians, the number of patients diagnosed as having cetuximab allergy and/or delayed red meat allergy, recall of tick bites, symptoms, time to reactions, elicitor foods, reactions with foods other than meat, and in-vivo and in-vitro tests used for the diagnosis.
Results. Seventy-nine physicians completed the questionnaire. Nine cases of allergy to cetuximab and 40 cases of delayed red meat allergy were recorded across Italy. 22.5% of patients with cetuximab allergy and 62.5% of those with delayed red meat allergy recalled a tick bite. 75% of patients with delayed red meat allergy experienced symptoms after eating beef (butcher's cut in
72.5%). Urticaria was the most frequent clinical manifestation (65% of cases). In 60.6% of cases symptoms appeared 2 - 4 hours after meat ingestion, while in 7.9% symptoms appeared after > 4 hours. The most used diagnostic methods were the intradermal test for cetuximab allergy (88.9%) and the detection of IgE to á-Gal (55.5%) for red meat allergy. Most case reports came from Northern Italy.
Conclusion. á-Gal syndrome is present in Italy and beef is the most frequent offending food. In most cases symptoms were not severe.
Key wordsá-Gal syndrome; red meat allergy; cetuximab allergy; survey
FULL TEXTCite this article as:
Villalta D et al. Galactose-á-1,3-galactose syndrome: an Italian survey. Eur Ann Allergy Clin Immunol. 2017;49(6):263-269. doi:10.23822/EurAnnACI.1764-1489.35